Ultrasound-Guided Injection of Stifle Joint in Dogs for Therapeutic Purposes

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Ultrasound guidance offers superior precision for intra-articular stifle injections in dogs compared to palpation-based methods, enabling real-time visualization of the needle tip to avoid periarticular vasculature and collateral ligaments. This technique is indicated for both diagnostic synovial fluid acquisition and therapeutic delivery of agents like corticosteroids, viscosupplements, or biologics.
• A linear array transducer (2-14 MHz, ~50 mm footprint) is recommended for stifle imaging, with the limb prepared aseptically and a sterile coupling medium (e.g., 70% isopropyl alcohol) used. The in-plane, long-axis needle orientation allows continuous visualization of the needle shaft and tip.
• Confirmation of intra-articular needle placement is achieved through direct visualization of the needle tip within the joint space, aspiration of synovial fluid, and observation of injectate entering and expanding the joint space under real-time ultrasound. This minimizes iatrogenic tissue trauma and reduces the number of needle attempts.
• Key anatomical structures to avoid during stifle injection include the lateral collateral ligament, patellar tendon, menisci, and periarticular vasculature such as branches of the popliteal artery and vein.
• Therapeutic agents commonly injected include corticosteroids for anti-inflammatory effects and hyaluronan for viscosupplementation, primarily for managing osteoarthritis. Accurate intra-articular delivery is crucial to maximize efficacy and prevent local tissue irritation or atrophy from extracapsular deposition.
• The evidence base primarily consists of technique descriptions and video tutorials; large comparative trials demonstrating superior clinical outcomes over blind techniques are limited. Clinicians must possess adequate training and practice to interpret ultrasound images and ensure needle tip visualization to mitigate risks of iatrogenic cartilage damage or extra-articular deposition.

Ultrasound-guided injection of the canine stifle offers a precise alternative to blind or palpation-guided techniques for delivering therapeutic agents into the joint space. This article provides the procedural foundation for veterinarians who perform diagnostic arthrocentesis or therapeutic intra-articular injection in dogs, with emphasis on imaging anatomy, needle guidance principles, and clinical decision-making. The content addresses the practicing clinician seeking a reproducible technique that minimizes iatrogenic tissue trauma and confirms intra-articular needle placement before drug delivery.

The procedure serves two linked purposes: diagnostic sampling of synovial fluid and therapeutic delivery of agents such as corticosteroids, viscosupplements, or biologic preparations. Ultrasound guidance confers advantages over blind approaches by allowing real-time visualization of the needle tip, avoidance of periarticular vasculature and soft tissue structures, and confirmation that injectate enters and expands the joint space. These benefits reduce the number of needle attempts and the risk of inadvertent extracapsular deposition, which can diminish therapeutic efficacy or cause local tissue irritation.

This article assumes familiarity with basic ultrasonographic image acquisition and machine operation. It does not cover arthroscopy, surgical treatment of stifle disease, or advanced imaging modalities beyond their role in confirming needle placement.

At a Glance

Rationale for Ultrasound Guidance

Blind arthrocentesis of the stifle relies on palpable landmarks and often requires multiple attempts, particularly in obese patients or those with effusion localized to a specific compartment. Ultrasound guidance allows the operator to identify fluid pockets, confirm needle entry into the visible joint space, and avoid structures of concern. A published video tutorial on ultrasound-guided arthrocentesis and intra-articular injection of the canine elbow and stifle describes the technique as reducing iatrogenic tissue damage from inappropriate needle placement and minimizing the number of attempts required for successful joint access. The same source emphasizes that ultrasound guidance can maximize joint fluid volume acquisition for diagnostic purposes, including cytology and culture.

The precision afforded by ultrasound extends beyond the stifle joint itself. Cadaveric evaluation of an ultrasound-guided adductor canal block technique demonstrated that high-frequency linear transducer guidance allowed reliable deposition of injectate around targeted nerves without intraneural or intravascular spread. While that study addressed regional anesthesia instead of intra-articular injection, it illustrates the general principle that real-time ultrasound guidance improves accuracy of needle placement in the canine pelvic limb and reduces collateral tissue injury.

Relevant Stifle Anatomy

The canine stifle is a complex joint comprising the femorotibial articulation, the femoropatellar joint, and the proximal tibiofibular joint. The joint capsule is continuous between the femoropatellar and femorotibial compartments in most dogs, which means that injectate placed in one compartment can distribute to others. The patellar ligament lies ventral to the joint and serves as a palpable landmark, while the medial and lateral collateral ligaments reinforce the joint capsule on their respective sides.

For ultrasound-guided approaches, the operator must identify the patellar ligament, the femoral trochlea, the tibial plateau, and the fat pad that occupies the space between the patellar ligament and the femoral condyles. The joint space is visible as a hypoechoic cleft between the femoral condyle and tibial plateau, and the presence of effusion widens this space and improves sonographic visibility. The medial and lateral menisci appear as triangular hyperechoic structures within the joint space and must not be penetrated by the needle.

The vascular supply around the stifle includes the popliteal artery and vein caudally, the descending genicular artery medially, and branches of the saphenous artery. Ultrasound guidance helps the operator avoid these vessels, particularly when using a lateral or caudolateral approach. The technique described in the veterinary literature places the needle in long axis with the probe and angles it at the appropriate trajectory to enter the visible joint space, with the needle tip visualized entering the joint before any injection occurs.

Imaging Technique and Probe Selection

A linear array transducer with a frequency range of 2 to 14 MHz and a footprint of approximately 50 mm is suitable for stifle imaging in most dogs. Higher frequencies within this range provide better resolution of superficial structures, while lower frequencies improve penetration in large or heavily muscled patients. The limb is clipped over the target window and prepared sterilely. The coupling medium may be 70% isopropyl alcohol instead of ultrasound gel, as alcohol does not require removal before needle insertion and maintains a sterile field.

The joint is visualized in long axis, meaning the probe is oriented parallel to the long axis of the limb. This orientation allows the needle to be inserted in-plane, so the entire needle shaft and tip remain visible throughout the procedure. The operator identifies the femoral condyle, tibial plateau, and joint space, then advances the needle bevel up at the appropriate angle to enter the joint. Aspiration of synovial fluid confirms placement and provides diagnostic material, after which the syringe is exchanged for one containing the therapeutic agent. Injection is performed under real-time visualization, with the injectate seen entering or expanding the joint space.

Clinical Applications and Therapeutic Agents

Therapeutic intra-articular injection of the canine stifle is most commonly performed for management of osteoarthritis, particularly in patients with cranial cruciate ligament disease or degenerative joint disease. Agents used include corticosteroids for anti-inflammatory effect, hyaluronan for viscosupplementation, and autologous conditioned serum or platelet-rich plasma for purported disease-modifying effects. The choice of agent depends on the underlying pathology, patient factors, and clinician preference, and current formulary and label references must be consulted for dosing and contraindications.

Ultrasound guidance is particularly valuable when the goal is to deliver a therapeutic agent into a specific compartment or when the joint is difficult to access by palpation. The ability to confirm intra-articular placement before injecting reduces the risk of delivering corticosteroids into periarticular tissues, where they can cause soft tissue atrophy or tendon weakening. For biologic agents, accurate intra-articular delivery is essential because extracapsular deposition wastes expensive material and may not provide clinical benefit.

Limitations and Evidence Considerations

The published evidence for ultrasound-guided stifle injection in dogs consists primarily of technique descriptions and video tutorials instead of large comparative trials. A video tutorial on ultrasound-guided arthrocentesis and intra-articular injection of the canine elbow and stifle provides the procedural framework described in this article, but it does not report outcome data comparing ultrasound guidance with blind techniques. The adductor canal block study provides supportive evidence for the accuracy of ultrasound-guided needle placement in the canine pelvic limb, but it evaluated a different target and used cadaveric specimens.

Clinicians should recognize that ultrasound guidance requires training and practice. Image interpretation errors, poor probe-patient contact, and failure to visualize the needle tip can all compromise the procedure. The operator must be prepared to abandon the approach if the needle tip cannot be clearly identified, as blind advancement under ultrasound guidance carries the same risks as a blind technique without the benefit of real-time confirmation.

Pre-Procedural Assessment and Patient Preparation

The decision to perform an ultrasound-guided stifle injection begins with a complete orthopedic examination. Confirm that the joint is the source of lameness before injecting. Palpate for effusion, crepitus, and periarticular thickening, and compare range of motion between limbs. Radiographs should be reviewed for evidence of degenerative joint disease, osteophytosis, or intra-articular mineralisation that might alter the approach or the choice of agent. When sepsis is suspected, arthrocentesis for cytology and culture should precede any therapeutic injection.

Patient positioning depends on the planned portal. Lateral recumbency with the affected limb uppermost provides access to the lateral pouch of the femorotibial joint and is the most commonly used position. Dorsal recumbency with the limb extended allows a cranial approach but is less frequently needed for therapeutic injection. Sedation is usually required, particularly in painful or fractious patients. A combination of an opioid and a benzodiazepine or alpha-2 agonist, titrated to effect, provides restraint without interfering with the procedure. General anesthesia is reserved for patients that remain reactive despite sedation or when the clinician anticipates difficulty.

Clip a window over the planned injection site. The window should extend from the patellar ligament cranially to the lateral collateral ligament caudally, and from the distal femur proximally to the proximal tibia distally. Aseptic preparation with chlorhexidine or povidone-iodine solution follows the same protocol used for arthrocentesis. Sterile ultrasound gel or a sterile alcohol medium is used within the prepared field. The ultrasound-guided arthrocentesis and intra-articular injection technique described by Miller and colleagues uses 70% isopropyl alcohol as the coupling medium, which avoids the image degradation caused by gel bubbles and maintains a sterile field.

Equipment Selection

A linear array transducer with a frequency range of 2 to 14 MHz and a footprint of approximately 50 mm is suitable for the canine stifle, as described in the video tutorial on ultrasound-guided arthrocentesis and injection of the canine stifle joint. Smaller patients may benefit from a higher frequency setting to improve near-field resolution, while larger patients may require lower frequencies for adequate penetration. A standoff pad is rarely necessary in the stifle because the joint is superficial.

Needle selection follows the depth of the target. A 22 gauge, 2.5 cm needle is adequate for most dogs. Larger breeds may require a 22 gauge, 5 cm spinal needle to reach the joint space through increased soft tissue. An extension set with a three-way stopcock allows the syringe to be changed without moving the needle tip, which is particularly useful when aspirating synovial fluid before injecting the therapeutic agent. The in-plane technique with the needle inserted bevel up allows continuous visualization of the needle shaft and tip throughout the procedure.

Needle Placement Technique

Position the transducer in a sagittal or parasagittal plane over the lateral femorotibial joint space. Identify the distal femur, proximal tibia, and the joint space between them. The lateral femoral condyle appears as a curved hyperechoic line with distal acoustic shadowing. The joint space is identified as a hypoechoic gap between the femoral condyle and the tibial plateau. The lateral collateral ligament appears as a fibrillar structure running obliquely across the joint and should be avoided.

Insert the needle at the cranial or caudal edge of the transducer footprint, directed toward the joint space in the same plane as the ultrasound beam. Advance the needle slowly while watching the screen. The needle tip appears as a bright hyperechoic point. When the tip contacts the joint capsule, a subtle indentation of the capsule may be visible before the needle penetrates it. Entry into the joint space is confirmed by loss of resistance and, when effusion is present, by aspiration of synovial fluid.

The ultrasound-guided approach described by Miller and colleagues emphasizes visualizing the needle tip entering the joint before any injection is performed. If the tip cannot be visualized clearly, do not advance further. Withdraw the needle partially and redirect. Repeated blind probing increases the risk of iatrogenic cartilage damage and soft tissue trauma, which ultrasound guidance is intended to prevent.

Injection and Confirmation of Placement

Once the needle tip is within the joint space, aspirate gently. Synovial fluid return confirms intra-articular placement and provides a sample for cytology if not already obtained. If no fluid returns, the joint may be dry or the needle may be against synovium. A small test injection of 0.5 to 1 mL of sterile saline can be used to confirm placement. Under ultrasound, the injectate is seen as an anechoic expansion of the joint space. The injectate can be visualized entering and expanding the joint upon injection, which is the definitive confirmation of correct needle placement.

Resistance to injection suggests the needle tip is not within the joint space. Common causes include placement within the synovial membrane, within periarticular fat, or against articular cartilage. Stop injecting and re-evaluate needle position with ultrasound before continuing.

The volume of injectate depends on the size of the patient and the agent being used. The joint capsule will accommodate a finite volume before distension becomes painful. Inject slowly and stop when resistance increases or when the joint capsule appears distended on ultrasound. For therapeutic agents such as corticosteroids, viscosupplements, or platelet-rich plasma, the volume is typically small, often 1 to 3 mL depending on patient size. Current formulary and label references should be consulted for specific product volumes and concentrations.

Post-Injection Care and Monitoring

After needle removal, apply gentle pressure to the injection site for one to two minutes to minimize hemorrhage. A light bandage is optional and is usually unnecessary. The patient should be rested for 24 to 48 hours after the procedure. Controlled leash walks are permitted, but running, jumping, and unrestricted activity should be avoided during this period to allow the injectate to distribute within the joint and to prevent excessive loading of an already compromised joint.

Monitor the patient for signs of injection site reaction, including increased lameness, swelling, or heat. A transient increase in lameness can occur within 24 hours after corticosteroid injection and usually resolves spontaneously. Persistent or worsening lameness beyond 48 hours warrants re-evaluation. Septic arthritis is the most serious complication and presents with acute severe lameness, joint effusion, and systemic signs. Owners should be advised to seek immediate veterinary attention if these signs develop.

Document the procedure in the medical record. Record the patient position, transducer orientation, needle gauge and length, the volume and type of injectate, the number of attempts, and any complications. Include ultrasound images or a description of the findings, particularly the confirmation of intra-articular placement. This documentation supports future comparison if the injection is repeated and provides a record of the therapeutic plan.

Decision Framework for Approach Selection

The lateral approach is preferred for most therapeutic injections because it offers the shortest needle path and the clearest ultrasound window. The cranial approach is reserved for specific indications, such as when the cranial pouch is the primary target or when the lateral approach is compromised by soft tissue swelling. In either approach, the ultrasound guidance reduces iatrogenic tissue damage from inappropriate needle placement and minimizes the number of attempts, which is particularly valuable in patients with pre-existing joint disease.

Patient size and temperament may alter the choice of sedation protocol and needle length. Brachycephalic breeds with thick periarticular soft tissue may require a longer needle. Obese patients present a greater challenge because the joint space is deeper and the acoustic window is narrower. In these patients, a lower frequency setting on the transducer and a longer needle are appropriate. The procedure should be abandoned if the joint space cannot be identified with confidence, and an alternative approach, such as fluoroscopic guidance or blind arthrocentesis, should be considered.

Complications and Failure Modes

Intra-articular injection failure occurs when the therapeutic agent is deposited outside the joint capsule, into periarticular fat, muscle, or the infrapatellar fat pad. Ultrasound guidance reduces but does not eliminate this risk. Needle tip visualization is the primary safeguard, when the tip cannot be confidently identified, the injection should not proceed. The most common early indicator of extra-articular placement is loss of the characteriztic distension of the joint capsule during injection. A second indicator is unexpected resistance to flow, which suggests the needle has engaged fibrous tissue or the patellar ligament.

Iatrogenic cartilage damage can occur when the needle tip contacts the femoral trochlea or tibial plateau. This is detected during the procedure as a visible indentation of the hyperechoic subchondral bone margin on the ultrasound image. The needle should be withdrawn 1 to 2 mm before injecting. Hemorrhage into the joint or periarticular tissues is usually self-limiting but can obscure subsequent imaging. The approach described in the video tutorial on ultrasound-guided arthrocentesis and intra-articular injections of the elbow and stifle joint in the dog emphasizes that ultrasound guidance helps avoid surrounding vasculature and soft tissue structures of concern, which directly reduces this complication Miller A, Jennings C, Frye C, institutional publication.

Infection is uncommon with strict aseptic technique but must be considered when the joint becomes painful, swollen, or warm within 48 to 72 hours after injection. Synoviocentesis for cytology and culture is the discriminating test. Septic arthritis requires immediate systemic antimicrobial therapy and joint lavage, and referral is warranted.

Common Operator Errors

Less experienced clinicians frequently misidentify the needle tip as the needle shaft. The shaft is hyperechoic and appears as a bright line, the tip is the point where that line terminates. Rotating the probe or using a slight heel-toe tilt can resolve ambiguity. Another common error is advancing the needle too far, penetrating the caudal joint capsule and entering the popliteal fat. The corrective action is to watch the tip continuously and stop the instant it crosses the synovial membrane.

Inadequate probe pressure or an off-axis scan plane produces a false image of the joint space. The femorotibial joint space is best visualized with the limb in a neutral or slightly extended position and the probe oriented in a long axis to the patellar ligament. If the joint space appears collapsed or indistinct, the probe should be repositioned instead of the needle redirected blindly.

A third error is aspirating before injecting and mistaking a dry tap for failed placement. A dry tap does not rule out intra-articular needle position, particularly in joints with minimal effusion. Conversely, a successful aspirate confirms placement but does not guarantee that the needle will remain intra-articular during syringe exchange. The needle hub should be stabilized with a hemostat or the operator's non-dominant hand during exchange.

Troubleshooting Table

Evidence Limitations and Expert Disagreement

The evidence base for ultrasound-guided stifle injection in dogs is limited to technique descriptions and small case series. The video tutorial referenced above provides procedural guidance but does not report comparative outcomes against blind injection Miller A, Jennings C, Frye C, institutional publication. No published randomized trial has demonstrated superior clinical outcomes for ultrasound-guided versus landmark-based stifle injection in dogs. Expert opinion differs on whether ultrasound guidance is mandatory for all stifle injections or reserved for obese patients, joints with effusion, and revision injections after failed blind attempts.

Regional anesthesia techniques around the stifle, such as the adductor canal block, have been evaluated in cadavers with variable nerve staining success, and the authors noted that contrast distribution reached the popliteal fossa in most but not all limbs Castro DS, Garcia-Pereira F, Giglio RF, institutional publication. This variability underscores that perineural and periarticular injection techniques carry inherent uncertainty, and clinicians should not assume that ultrasound guidance guarantees complete neural coverage.

Referral and Escalation Criteria

Referral to a veterinary radiologist or board-certified surgeon is appropriate when the joint cannot be visualized adequately despite repositioning, when the patient is obese or heavily muscled and the needle tip cannot be tracked, or when repeated attempts have failed to achieve intra-articular placement. Specialist consultation is also warranted for patients with suspected septic arthritis, coagulopathy, or a history of adverse reactions to injectable agents.

Laboratory involvement is indicated when synovial fluid is obtained and appears turbid, hemorrhagic, or low in viscosity. Cytology, total protein, and culture should be performed before any corticosteroid is injected. Regulatory reporting obligations vary by jurisdiction, clinicians should consult their local veterinary board or the American Veterinary Medical Association practice resources for guidance on adverse event reporting related to injectable therapeutics.

Frequently Asked Questions

How many attempts should be made before abandoning a percutaneous ultrasound-guided stifle injection?

Limit attempts to two or three needle passes per session. Each failed pass increases periarticular tissue trauma, synovial hemorrhage, and the risk of inadvertent neurovascular puncture. The ultrasound-guided arthrocentesis and intra-articular injection tutorial emphasizes that needle guidance reduces iatrogenic tissue damage by minimizing attempts. If the tip cannot be visualized entering the joint after three passes, reassess probe orientation, confirm the target window, and consider whether patient positioning or effusion volume has changed. Re-scan the entire joint to identify unexpected anatomic variation. If placement remains uncertain, stop and refer to a colleague with more ultrasound experience instead of persisting blindly.

What can be done when a high-frequency linear transducer is unavailable?

A microconvex or curvilinear probe with a frequency range that includes 7 to 10 MHz can serve as an alternative for stifle work in larger dogs. Image quality degrades at depth, so use the highest frequency the probe supports and adjust gain and focal zone to the joint depth. In small dogs and cats, a high-frequency linear probe is strongly preferred because the joint space is shallow and near-field resolution is critical. When only a low-frequency probe is available, consider abandoning ultrasound guidance and using a landmark-based approach with careful aspiration before injection. The ACVR professional resources provide guidance on probe selection and image optimization for musculoskeletal applications.

How should the procedure be documented in the medical record?

Record the patient signalment, indication for injection, therapeutic agent and volume, probe type and frequency, approach used, number of needle passes, and whether injectate was visualized entering the joint. Note any synovial fluid aspirated, its gross appearance, and whether samples were submitted for cytology or culture. Document the patient's response to sedation or anesthesia, any complications encountered, and post-injection assessment of lameness or comfort. Include representative ultrasound images or a video clip in the record when possible. This documentation supports continuity of care, medicolegal defense, and outcome tracking. The AVMA practice resources offer guidance on medical record standards for veterinary procedures.

How does the technique differ in cats or small-breed dogs?

The stifle joint in cats and small dogs is shallower, and the needle trajectory angle must be reduced accordingly. Use a smaller gauge needle, typically 25 or 27 gauge, and reduce injectate volume proportionally to joint capacity. The patellar ligament is relatively wider compared with the joint, so the parapatellar approach may be easier than a midline patellar ligament approach. Probe pressure must be minimized to avoid collapsing the already small joint space. Sedation requirements are similar, but smaller patients lose heat faster, so warming the ultrasound gel and injectate matters more. The MSD Veterinary Manual provides species-specific joint anatomy and arthrocentesis guidance relevant to these adaptations.

What are the cost and resource considerations for adding ultrasound guidance to routine stifle injections?

Ultrasound guidance adds procedure time, typically 5 to 10 minutes, and requires access to an ultrasound machine with a high-frequency probe, sterile gel or alcohol, and sterile probe cover. Consumable costs are modest, but the capital cost of a suitable machine is substantial. Practices without an in-house unit may refer therapeutic injections to a specialty center or continue with landmark-based techniques. The time cost is offset by fewer failed injections and reduced repeat procedures. For high-value patients, such as working dogs or those with recurrent lameness, the improved accuracy justifies the added expense. The AVMA practice resources discuss economic decision-making for diagnostic imaging equipment acquisition.

How should a client be counseled when ultrasound-guided injection is recommended but not available?

Explain that ultrasound guidance improves needle placement accuracy and reduces the number of attempts needed, which lowers the risk of tissue trauma and improves the chance that the therapeutic agent reaches the joint space. The ultrasound-guided arthrocentesis and intra-articular injection tutorial describes these benefits directly. If referral is not feasible, discuss the alternative of a landmark-based injection with its higher failure rate and the option of radiographic contrast confirmation if available. Be transparent about the evidence base: comparative studies of ultrasound versus landmark guidance in canine stifles are limited, and clinical judgment remains important. Offer a clear recommendation based on the patient's size, temperament, and the specific therapeutic goal.

Related Clinical & Scientific Guides

• MRI Monitoring of Brain Tumor Response to Therapy in Dogs
• Ultrasound-Guided Drainage of Abscesses in Small Animals
• Radiographic Monitoring of Total Hip Replacement in Dogs

References and Further Reading

• Ultrasound-guided arthrocentesis and intra-articular injections of the elbow and stifle joint in the dog.. 2025.
• Evaluation of the potential efficacy of an ultrasound-guided adductor canal block technique in dog cadavers.. 2018.
• Novel ultrasound-guided flags assisted WalKing block for enhanced recovery after surgery (FAWKES) in three dogs undergoing tibial plateau levelling osteotomy.. 2026.
• Evaluation of a positioning method for equine lateral stifle scintigrams.. 2012.
• American College of Veterinary Radiology Resources. American College of Veterinary Radiology.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.
• American Veterinary Medical Association Practice Resources. American Veterinary Medical Association.
• WOAH Terrestrial Animal Health Code. WOAH.

Related Articles

• Ultrasound-Guided Injection of Joints in Horses for Therapeutic Purposes
• Ultrasound-Guided Injection of Sacroiliac Joint in Dogs for Pain Management
• Ultrasound-Guided Cystocentesis for Therapeutic Drainage in Dogs and Cats
• Ultrasound-Guided Pericardiocentesis for Therapeutic Drainage in Dogs
• Ultrasound-Guided Abdominocentesis for Therapeutic Paracentesis in Small Animals

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.